Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-04-26

Clinical Trial Update: Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML [NA]

View source ↗

Summary

This document reports on a clinical trial evaluating the MTBF conditioning regimen for salvageable allogeneic hematopoietic stem cell transplantation in relapse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MTBF conditioning regimen

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Relapse Leukemia, Refractory Acute Myeloid Leukemia | NA | Status: NOT_YET_RECRUITING